TY - JOUR
T1 - Epidemiology of adult patients with atopic dermatitis in AWARE 1
T2 - A second international survey
AU - Maspero, Jorge
AU - De Paula Motta Rubini, Norma
AU - Zhang, Jianzhong
AU - Sanclemente, Gloria
AU - Amador, Julio Roberto
AU - El Sayed, Mahira Hamdy
AU - Chan Wai Ming, Alson
AU - Dodiuk-Gad, Roni P.
AU - Hamadah, Issam
AU - Thevarajah, Suganthi
AU - Rincón-Perez, Catalina
AU - Fedenko, Elena
AU - Yew, Yik Weng
AU - Tang, Mark B.Y.
AU - Chu, Chia Yu
AU - Kulthanan, Kanokvalai
AU - Kucuk, Ozlem Su
AU - Al-Hammadi, Anwar
AU - Brignoli, Lysel
AU - Tsankova, Angelina
AU - El-Samad, Sarah
AU - Neves, Jose Eduardo
AU - Eckert, Laurent
N1 - Publisher Copyright:
© 2022 The Authors
PY - 2023/3
Y1 - 2023/3
N2 - Background: There are gaps in our understanding of the epidemiology of atopic dermatitis (AD) in adults. Objective: To evaluate the prevalence and severity of AD in adults from countries/regions within Asia, Eurasia, Latin America, Middle East, and Russia. Methods: This international, web-based survey was performed in Argentina, Brazil, China, Colombia, Egypt, Hong Kong, Israel, Malaysia, Mexico, Russia, Kingdom of Saudi Arabia (KSA), Singapore, Taiwan, Thailand, Turkey, and United Arab Emirates. Questionnaires were sent to adult members of online respondent panels for determination of AD and assessment of severity. A diagnosis of AD required respondents to meet the modified United Kingdom (UK) Working Party criteria and to self-report they had a physician diagnosis of AD. Severity of AD was determined using Patient-Oriented Scoring of Atopic Dermatitis (PO-SCORAD), Patient-Oriented Eczema Measure (POEM), and Patient Global Assessment (PGA). Results: Among respondents by country/region the prevalence of AD ranged from 3.4% in Israel to 33.7% in Thailand. The prevalence was generally higher in females versus males. Severity varied by scale, although regardless of scale the proportion of respondents with mild and moderate disease was higher than severe disease. PGA consistently resulted in the lowest proportion of severe AD (range 2.4% China – 10.8% Turkey) relative to PO-SCORAD (range 13.4% China – 41.6% KSA) and POEM (range 5.1% China – 16.6% Israel). Conclusions: This survey highlights the importance of AD in adults, with high prevalence and high morbidity among respondents and emphasizes that AD is not just a disease of childhood—there is disease persistence and chronicity in adults.
AB - Background: There are gaps in our understanding of the epidemiology of atopic dermatitis (AD) in adults. Objective: To evaluate the prevalence and severity of AD in adults from countries/regions within Asia, Eurasia, Latin America, Middle East, and Russia. Methods: This international, web-based survey was performed in Argentina, Brazil, China, Colombia, Egypt, Hong Kong, Israel, Malaysia, Mexico, Russia, Kingdom of Saudi Arabia (KSA), Singapore, Taiwan, Thailand, Turkey, and United Arab Emirates. Questionnaires were sent to adult members of online respondent panels for determination of AD and assessment of severity. A diagnosis of AD required respondents to meet the modified United Kingdom (UK) Working Party criteria and to self-report they had a physician diagnosis of AD. Severity of AD was determined using Patient-Oriented Scoring of Atopic Dermatitis (PO-SCORAD), Patient-Oriented Eczema Measure (POEM), and Patient Global Assessment (PGA). Results: Among respondents by country/region the prevalence of AD ranged from 3.4% in Israel to 33.7% in Thailand. The prevalence was generally higher in females versus males. Severity varied by scale, although regardless of scale the proportion of respondents with mild and moderate disease was higher than severe disease. PGA consistently resulted in the lowest proportion of severe AD (range 2.4% China – 10.8% Turkey) relative to PO-SCORAD (range 13.4% China – 41.6% KSA) and POEM (range 5.1% China – 16.6% Israel). Conclusions: This survey highlights the importance of AD in adults, with high prevalence and high morbidity among respondents and emphasizes that AD is not just a disease of childhood—there is disease persistence and chronicity in adults.
KW - Atopic dermatitis
KW - Epidemiology
KW - PO-SCORAD
KW - POEM
KW - Prevalence
KW - Severity
UR - https://www.scopus.com/pages/publications/85150848672
U2 - 10.1016/j.waojou.2022.100724
DO - 10.1016/j.waojou.2022.100724
M3 - Article
AN - SCOPUS:85150848672
SN - 1939-4551
VL - 16
JO - World Allergy Organization Journal
JF - World Allergy Organization Journal
IS - 3
M1 - 100724
ER -